In the 7MM, the total prevalent cases of schizophrenia were 5,121,015 in 2021. The cases are expected to grow at an AGR of less than 1% during the period 2021-2031. Schizophrenia is a chronic and debilitating mental illness, characterized by delusions, hallucinations, disorganized speech, trouble with thinking, and a lack of motivation. Schizophrenia is among the most disabling and economically catastrophic medical disorders, ranked by the World Health Organization (WHO) as one of the top 10 illnesses contributing to the global burden of disease. The disorder is characterized by the presence of both positive and negative symptoms.
For more insights, download a free report sample
Age-Specific 12-Month Diagnosed Prevalent Cases of Schizophrenia
The key age segments in the 12-month diagnosed prevalent cases of schizophrenia are 13-17 years, 18-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and more than 80. In 2021, for the 7MM combined, adults ages 50–59 years contributed the highest proportion of the 12-month diagnosed prevalent cases of schizophrenia.
Age-Specific 12-Month Diagnosed Prevalent Cases of Schizophrenia
For more key age segment insights, download a free report sample
COVID-19 Impact in the Schizophrenia Epidemiology Market
The coronavirus disease 2019 (COVID-19) is likely to have far-reaching consequences as global healthcare systems have been redirected to focus on fighting the pandemic. The impact of the COVID-19 pandemic may include a shortage of medical staff, decreased access to treatment, a delay in diagnosis, decreased survival, and an increase in disease incidence related to coronavirus infections. The COVID-19 pandemic is having a critical impact on healthcare systems globally, as well as on mental health in the general population. People living with schizophrenia are at an increased risk of COVID-19 and present worse COVID-19-related outcomes, including mortality. They show low levels of information and concern regarding the possibility of contagion and infection but presented substantially stable levels of psychotic symptoms and even increased subjective well-being during the pandemic.
Market report overview
|Market size 2021||5,121,015 cases|
|Key age segments||13-17 years, 18-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and >80|
- This report provides an overview of the risk factors, comorbidities, and the global and historical trends for schizophrenia in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report provides a 10-year epidemiological forecast for 12‒month total prevalent cases and 12‒month diagnosed prevalent cases of schizophrenia.
- The 12‒month diagnosed prevalent cases of schizophrenia are further segmented by age (13–17 years, 18–19 years, 20–29 years, 30–39 years, 40–49 years, 50–59 years, 60–69 years, 70–79 years, and 80 years and older) in these markets. The model accompanying this report also provides the 12-month total prevalent cases and 12-month diagnosed prevalent cases of schizophrenia and the listed segments. The schizophrenia epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
- The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The schizophrenia epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global schizophrenia market.
- Quantify patient populations in the global schizophrenia market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for schizophrenia therapeutics in each of the markets covered.
- Enable to understand the magnitude of 12-month diagnosed prevalence of schizophrenia.
Table of Contents
| About GlobalData
1 Schizophrenia: Executive Summary
1.2 Related reports
1.3 Upcoming reports
2.1 Disease background
2.2 Risk factors and comorbidities
2.3 Global and historical trends
2.4 7MM forecast methodology
2.4.2 Forecast assumptions and methods
2.4.3 Forecast assumptions and methods: 12-month total prevalent cases of schizophrenia
2.4.4 Forecast assumptions and methods: 12-month diagnosed prevalent cases of schizophrenia
2.5 Epidemiological forecast for schizophrenia (2021–31)
2.5.1 12-Month total prevalent cases of schizophrenia
2.5.2 12-Month diagnosed prevalent cases of schizophrenia
2.5.3 Age-specific 12-month diagnosed prevalent cases of schizophrenia
2.5.4 Sex-specific 12-month diagnosed prevalent cases of schizophrenia
2.6.1 Epidemiological forecast insight
2.6.2 COVID-19 impact
2.6.3 Limitations of the analysis
2.6.4 Strengths of the analysis
3.2 About the authors
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
| Contact Us
List of Tables
Table 1: Summary of newly added data types
Table 2: Summary of updated data types
Table 3: Risk factors and comorbid conditions associated with schizophrenia
List of Figures
Figure 1: 7MM, 12-month total prevalent cases of schizophrenia, both sexes, N, ages ≥13 years, 2021 and 2031
Figure 2: 7MM, 12-month diagnosed prevalent cases of schizophrenia, both sexes, N, ages ≥13 years, 2021 and 2031
Figure 3: 7MM, 12-month total prevalence (%) of schizophrenia, both sexes, ages ≥13 years, 2021
Figure 4: 7MM, 12-month diagnosed prevalence (%) of schizophrenia, men and women, ages ≥13 years, 2021
Figure 5: 7MM, sources used to forecast the 12-month total prevalent cases of schizophrenia
Figure 6: 7MM, sources used and not used to forecast the 12-month diagnosed prevalent cases of schizophrenia
Figure 7: 7MM, 12-month total prevalent cases of schizophrenia, N, both sexes, ages ≥13 years, 2021
Figure 8: 7MM, 12-month diagnosed prevalent cases of schizophrenia, N, both sexes, ages ≥13 years, 2021
Figure 9: 7MM, 12-month diagnosed prevalent cases of schizophrenia by age, N, both sexes, 2021
Figure 10: 7MM, 12-month diagnosed prevalent cases of schizophrenia by sex, N, ages ≥13 years, 2021
Frequently Asked Questions
The total number of prevalent cases of schizophrenia were 5,121,015 in 2021.
The schizophrenia epidemiology market is expected to grow at an AGR of less than 1%.
The key age segments in the 12-month diagnosed prevalent cases of schizophrenia are 13-17 years, 18-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and more than 80.
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.